Magnesium Chloride Versus Placebo in Patients Who Have Had a Stroke

• Status: Completed
• Trial end date: 2010-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effect of six intravenous (IV) infusions of magnesium chloride versus placebo in patients who have residual muscle weakness from a stroke that occurred three months to four years ago.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Relox Medical, LLC

Criteria

Inclusion Criteria:

1. Subjects of either sex above 18 years of age

2. Documented history of stroke 3 months to four years ago

3. Subjects may have had two or more strokes

4. Must have residual muscle weakness with a 25% or greater difference in strength between the right and left sides of the body

5. Must be assessed as a 2 or 3 on the Modified Rankin Scale

6. Must have a Barthel score at or below 85

Exclusion Criteria:

1. Any traumatic brain injury or other brain injury apart from stroke

2. Renal insufficiency or renal failure

3. Any medical or physical condition that would interfere with the measurements to be conducted

4. Any physical therapy in a facility outside their home within three days of screening